NON-ST-SEGMENT-ELEVATION ACUTE CORONARY SYNDROME: PREVENTION DRUG THERAPY

Abstract

Nowadays, cardiovascular diseases (CVDs) that comprise a major portion of chronic non-communicable diseases are the leading cause of disease burdent and death in developed countries. The term acute coronary syndrome (ACS) covers any group of clinical symptoms consistent with acute myocardial ischemia. The classification of the ACS is based primarily on electrocardiogram (ECG) data. Depending on the ECG changes, the ACS is divided into patients with ST elevation (STE-ACS) versus patients with non-STelevation (NSTE-ACS). NSTE-ACS is increasingly the cause of hospitalization. There are conflicting views in the literature on the therapeutic strategies applied to different types of ACS. The strategies applied in the ACS need to take into account the patient‘s objective condition and accompanying illnesses to reduce shortand long-term mortality. Patients with NSTE-ACS are a non-homogeneous group against the risk of adverse cardiovascular events (MACE). The choice of a medical strategy for patients with NSTE-ACS is based on an individual case-by-case assessment. Cardioprotection is an integral part of the prevention of cardiovascular disease. The main purpose of prophylactic drug therapy in patients with cardiovascular diseases is to maximize the reduction of long-term risk for MACE and cerebrovascular disease; reducing recurrences and complications, requiring control of all identified risk factors. The purpose of this study is to review the literature on NSTE-ACS strategies in patients with a different risk profile and age; to determine which prophylactic drug therapy, tailored to the patient‘s objective condition and accompanying conditions, is assigned to patients with non-ST-elevation (NSTE-ACS) in order to prevent recurrences and complications.

Authors and Affiliations

Valentin Balabanski, Iliana Yaneva

Keywords

Related Articles

THE EUROPEAN FOOD SAFETY AUTHORITY AND THE ROLE OF FOCAL POINTS

A key task for European Food Safety Authority /EFSA/, and EU Member States, is the development and communication of high quality scientific opinions. These opinions need to be based on sound science involving Europe’s le...

MICROBIAL CONTAMINANTS IN BOTTLED WATER

Over the recent years, the consumption of bottled (mineral, spring, table) water has increased in Bulgaria. Quality of bottled water is regulated by both European and Bulgarian legislations. Regulations allow water treat...

DETERMINANTS OF TOBACCO USE AMONG BULGARIAN SCHOOLCHILDREN

The publication describes a part of results from both phases of the Global Youth Tobacco survey (2002 and 2008). It was carried out in a representative sample of Bulgarian schoolchildren from 7th- 9th grades in order to...

HEALTH PROMOTION AND DISEASE PREVENTION IN PRIMARY CARE

Survey results are presented of the opinions of general practitioners (GPs) on issues related to health promotion and disease prevention, and their role in the management of chronic non-communicable diseases (CNCD). The...

NATIONAL REPRESENTATIVE EPIDEMIOLOGICAL STUDY OF COMMON PSYCHIATRIC DISORDERS IN BULGARIA (2003-2007): TWELVEMONTH AND LIFETIME PREVALENCE, SEVERITY AND CO-MORBIDITY

Objectives: The aim of the current study is to provide epidemiological data for the annual (12 month) and lifetime prevalence, severity and co-morbidity in the following groups of common mental disorders in Bulgaria: An...

Download PDF file
  • EP ID EP471010
  • DOI -
  • Views 33
  • Downloads 0

How To Cite

Valentin Balabanski, Iliana Yaneva (2018). NON-ST-SEGMENT-ELEVATION ACUTE CORONARY SYNDROME: PREVENTION DRUG THERAPY. Българско списание за обществено здраве (Bulgarian Journal of Public Health), 0(1), 67-77. https://europub.co.uk/articles/-A-471010